価格表

在庫・価格 : 2025年05月15日 19時06分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IL-15, Mouse, Recombinant
データシート
447-ML-010 RSDアールアンドディー システムズ
R&D Systems, Inc.
10 μg ¥76,000 3個以上 追加

在庫・価格 : 2025年05月15日 19時06分 現在

IL-15, Mouse, Recombinant

  • 商品コード:447-ML-010
  • メーカー:RSD
  • 包装:10μg
  • 価格: ¥76,000
  • 在庫:3個以上
使用文献
No. 文献情報 備考 参照
1 Luther SA et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 2002 Jul;169(1):424-33
Luther SA et al
2002/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
2 Ogasawara K et al. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J. Immunol. 2002 Oct;169(7):3676-85
Ogasawara K et al
2002/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Ferretti S et al. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 2003 Feb;170(4):2106-12
Ferretti S et al
2003/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 Gil MP et al. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 2006 Feb;107(3):987-93
Gil MP et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Liuwantara D et al. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes 2006 Sep;55(9):2491-501
Liuwantara D et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Bredemeyer AJ et al. Hop cleavage and function in granzyme B-induced apoptosis. J. Biol. Chem. 2006 Dec;281(48):37130-41
Bredemeyer AJ et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Rafei M et al. A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex. Blood 2007 Mar;109(5):2234-42
Rafei M et al
2007/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Zheng SG et al. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 2007 Feb;178(4):2018-27
Zheng SG et al
2007/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
9 Wan N et al. Bystander central memory but not effector memory CD8+ T cells suppress allograft rejection. J. Immunol. 2008 Jan;180(1):113-21
Wan N et al
2008/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
10 Pan W et al. Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS. J. Neurochem. 2008 Jul;106(1):313-9
Pan W et al
2008/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
11 Wuest TY et al. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J. Leukoc. Biol. 2008 Oct;84(4):973-80
Wuest TY et al
2008/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Zaph C et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J. Exp. Med. 2008 Sep;205(10):2191-8
Zaph C et al
2008/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
13 Sikora AG et al. IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity. J. Immunol. 2009 Jun;182(12):7398-407
Sikora AG et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Pepper M et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 2010 Jan;11(1):83-9
Pepper M et al
2010/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
15 Barra NG et al. Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes. Obesity (Silver Spring) 2010 Aug;18(8):1601-7
Barra NG et al
2010/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
16 Tripathi P et al. STAT5 is critical to maintain effector CD8+ T cell responses. J. Immunol. 2010 Aug;185(4):2116-24
Tripathi P et al
2010/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
17 Kayamuro H et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J. Virol. 2010 Dec;84(24):12703-12
Kayamuro H et al
2010/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
18 Verbist KC et al. A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection. J. Immunol. 2011 Jan;186(1):174-82
Verbist KC et al
2011/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
19 DePaolo RW et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011 Mar;471(7337):220-4
DePaolo RW et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
20 Haddad D et al. Sense transcription through the S region is essential for immunoglobulin class switch recombination. EMBO J. 2011 Apr;30(8):1608-20
Haddad D et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
21 Soderquest K et al. Monocytes control natural killer cell differentiation to effector phenotypes. Blood 2011 Apr;117(17):4511-8
Soderquest K et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
22 Kurtulus S et al. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim. J. Immunol. 2011 May;186(10):5729-37
Kurtulus S et al
2011/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
23 Olkhanud PB et al. Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J. Immunol. 2011 May;186(10):5656-62
Olkhanud PB et al
2011/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
24 Freeman BE et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012 Jun;109(25):9971-6
Freeman BE et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
25 Sneddon JB et al. Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme. Nature 2012 Nov;491(7426):765-8
Sneddon JB et al
2012/01/01
Application: Cell Culture Substrate, Sample Type: whole cells PubMed
26 Michel ML et al. Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing γδ cells. Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(43):17549-54
Michel ML et al
2012/01/01
Application: Bioassay, Sample Type: whole cells PubMed
27 Zarling S et al. The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria. J. Immunol. 2013 May;190(10):5128-41
Zarling S et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
28 Dudda JC et al. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 2013 Apr;38(4):742-53
Dudda JC et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
29 Quinn LS et al. IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice. Endocrinology 2014 Jan;155(1):143-55
Quinn LS et al
2014/01/01
Sample Type: In Vivo PubMed
30 Dowty ME et al. Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis. J. Pharmacol. Exp. Ther. 2014 Jan;348(1):165-73
Dowty ME et al
2014/01/01
Application: Bioassay, Sample Type: Whole Blood PubMed
31 Khattar M et al. Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions. PLoS ONE 2014;9(1):e85882
Khattar M et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
32 Krupnick AS et al. Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J. Clin. Invest. 2014 Mar;124(3):1130-43
Krupnick AS et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
33 Freeman BE et al. Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions. J. Virol. 2014 Jul;88(13):7474-84
Freeman BE et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cell PubMed
34 Nish SA et al. T cell-intrinsic role of IL-6 signaling in primary and memory responses. Elife 2014;3:e01949
Nish SA et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
35 Mar巽ais A et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 2014 Aug;15(8):749-57
Mar巽ais A et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
36 Lee F et al. The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface. PLoS ONE 2014;9(7):e103254
Lee F et al
2014/01/01
Application: Bioassay, Sample Type: cell lines PubMed
37 Kurtulus S et al. Bim controls IL-15 availability and limits engagement of multiple BH3-only proteins. Cell Death Differ. 2015 Jan;22(1):174-84
Kurtulus S et al
2015/01/01
Application: In vivo injection, Sample Type: Whole Organism PubMed
38 Pennati A et al. Maltose-binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivatives. PLoS ONE 2014;9(9):e106724
Pennati A et al
2014/01/01
Application: Standard, Sample Type: Cell Lysates PubMed
39 Shehata HM et al. The aged nonhematopoietic environment impairs natural killer cell maturation and function. Aging Cell 2015 Apr;14(2):191-9
Shehata HM et al
2015/01/01
Application: In vivo injection, Sample Type: Whole Organism PubMed
40 Pobezinsky LA et al. Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat. Immunol. 2015 May;16(5):517-24
Pobezinsky LA et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
41 Ahmed Rahim MM et al. Normal development and function but impaired memory phenotype of CD8⁺ T cells in transgenic mice expressing HIV-1 Nef in its natural target cells. Virology 2013 Apr;438(2):84-97
Ahmed Rahim MM et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
42 Celis-Gutierrez J et al. Dok1 and Dok2 proteins regulate natural killer cell development and function. EMBO J. 2014 Sep;33(17):1928-40
Celis-Gutierrez J et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
43 Harris TL et al. Drak2 Does Not Regulate TGF-β Signaling in T Cells. PLoS ONE 2015;10(5):e0123650
Harris TL et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
44 Fiege JK et al. Negative Regulation of Memory Phenotype CD8 T Cell Conversion by Adhesion and Degranulation-Promoting Adapter Protein. J. Immunol. 2015 Oct;195(7):3119-28
Fiege JK et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
45 Golden-Mason L et al. Galectin-9 functionally impairs natural killer cells in humans and mice. J. Virol. 2013 May;87(9):4835-45
Golden-Mason L et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
46 Holmkvist P et al. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur. J. Immunol. 2016 Jun;46(6):1371-82
Holmkvist P et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
47 Jones RB et al. A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. PLoS Pathog. 2016 Apr;12(4):e1005545
Jones RB et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
48 Kavazović I et al. NKG2D stimulation of CD8(+) T cells during priming promotes their capacity to produce cytokines in response to viral infection in mice. Eur. J. Immunol. 2017 Jul;47(7):1123-1135
Kavazović I et al
2017/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
  • No.: 1
  • 文献情報:
    Luther SA et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 2002 Jul;169(1):424-33
    Luther SA et al
    2002/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ogasawara K et al. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J. Immunol. 2002 Oct;169(7):3676-85
    Ogasawara K et al
    2002/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ferretti S et al. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 2003 Feb;170(4):2106-12
    Ferretti S et al
    2003/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gil MP et al. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 2006 Feb;107(3):987-93
    Gil MP et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Liuwantara D et al. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes 2006 Sep;55(9):2491-501
    Liuwantara D et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Bredemeyer AJ et al. Hop cleavage and function in granzyme B-induced apoptosis. J. Biol. Chem. 2006 Dec;281(48):37130-41
    Bredemeyer AJ et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Rafei M et al. A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex. Blood 2007 Mar;109(5):2234-42
    Rafei M et al
    2007/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Zheng SG et al. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 2007 Feb;178(4):2018-27
    Zheng SG et al
    2007/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wan N et al. Bystander central memory but not effector memory CD8+ T cells suppress allograft rejection. J. Immunol. 2008 Jan;180(1):113-21
    Wan N et al
    2008/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Pan W et al. Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS. J. Neurochem. 2008 Jul;106(1):313-9
    Pan W et al
    2008/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Wuest TY et al. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J. Leukoc. Biol. 2008 Oct;84(4):973-80
    Wuest TY et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Zaph C et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J. Exp. Med. 2008 Sep;205(10):2191-8
    Zaph C et al
    2008/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Sikora AG et al. IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity. J. Immunol. 2009 Jun;182(12):7398-407
    Sikora AG et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Pepper M et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 2010 Jan;11(1):83-9
    Pepper M et al
    2010/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Barra NG et al. Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes. Obesity (Silver Spring) 2010 Aug;18(8):1601-7
    Barra NG et al
    2010/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Tripathi P et al. STAT5 is critical to maintain effector CD8+ T cell responses. J. Immunol. 2010 Aug;185(4):2116-24
    Tripathi P et al
    2010/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Kayamuro H et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J. Virol. 2010 Dec;84(24):12703-12
    Kayamuro H et al
    2010/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Verbist KC et al. A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection. J. Immunol. 2011 Jan;186(1):174-82
    Verbist KC et al
    2011/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    DePaolo RW et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011 Mar;471(7337):220-4
    DePaolo RW et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Haddad D et al. Sense transcription through the S region is essential for immunoglobulin class switch recombination. EMBO J. 2011 Apr;30(8):1608-20
    Haddad D et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Soderquest K et al. Monocytes control natural killer cell differentiation to effector phenotypes. Blood 2011 Apr;117(17):4511-8
    Soderquest K et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Kurtulus S et al. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim. J. Immunol. 2011 May;186(10):5729-37
    Kurtulus S et al
    2011/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Olkhanud PB et al. Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J. Immunol. 2011 May;186(10):5656-62
    Olkhanud PB et al
    2011/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Freeman BE et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U.S.A. 2012 Jun;109(25):9971-6
    Freeman BE et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Sneddon JB et al. Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme. Nature 2012 Nov;491(7426):765-8
    Sneddon JB et al
    2012/01/01
  • 備考:
    Application: Cell Culture Substrate, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Michel ML et al. Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing γδ cells. Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(43):17549-54
    Michel ML et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Zarling S et al. The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria. J. Immunol. 2013 May;190(10):5128-41
    Zarling S et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Dudda JC et al. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 2013 Apr;38(4):742-53
    Dudda JC et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Quinn LS et al. IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice. Endocrinology 2014 Jan;155(1):143-55
    Quinn LS et al
    2014/01/01
  • 備考:
    Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Dowty ME et al. Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis. J. Pharmacol. Exp. Ther. 2014 Jan;348(1):165-73
    Dowty ME et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Blood
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Khattar M et al. Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions. PLoS ONE 2014;9(1):e85882
    Khattar M et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Krupnick AS et al. Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J. Clin. Invest. 2014 Mar;124(3):1130-43
    Krupnick AS et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Freeman BE et al. Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions. J. Virol. 2014 Jul;88(13):7474-84
    Freeman BE et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cell
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Nish SA et al. T cell-intrinsic role of IL-6 signaling in primary and memory responses. Elife 2014;3:e01949
    Nish SA et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Mar巽ais A et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 2014 Aug;15(8):749-57
    Mar巽ais A et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Lee F et al. The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface. PLoS ONE 2014;9(7):e103254
    Lee F et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: cell lines
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Kurtulus S et al. Bim controls IL-15 availability and limits engagement of multiple BH3-only proteins. Cell Death Differ. 2015 Jan;22(1):174-84
    Kurtulus S et al
    2015/01/01
  • 備考:
    Application: In vivo injection, Sample Type: Whole Organism
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Pennati A et al. Maltose-binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivatives. PLoS ONE 2014;9(9):e106724
    Pennati A et al
    2014/01/01
  • 備考:
    Application: Standard, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Shehata HM et al. The aged nonhematopoietic environment impairs natural killer cell maturation and function. Aging Cell 2015 Apr;14(2):191-9
    Shehata HM et al
    2015/01/01
  • 備考:
    Application: In vivo injection, Sample Type: Whole Organism
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Pobezinsky LA et al. Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat. Immunol. 2015 May;16(5):517-24
    Pobezinsky LA et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Ahmed Rahim MM et al. Normal development and function but impaired memory phenotype of CD8⁺ T cells in transgenic mice expressing HIV-1 Nef in its natural target cells. Virology 2013 Apr;438(2):84-97
    Ahmed Rahim MM et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Celis-Gutierrez J et al. Dok1 and Dok2 proteins regulate natural killer cell development and function. EMBO J. 2014 Sep;33(17):1928-40
    Celis-Gutierrez J et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Harris TL et al. Drak2 Does Not Regulate TGF-β Signaling in T Cells. PLoS ONE 2015;10(5):e0123650
    Harris TL et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Fiege JK et al. Negative Regulation of Memory Phenotype CD8 T Cell Conversion by Adhesion and Degranulation-Promoting Adapter Protein. J. Immunol. 2015 Oct;195(7):3119-28
    Fiege JK et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Golden-Mason L et al. Galectin-9 functionally impairs natural killer cells in humans and mice. J. Virol. 2013 May;87(9):4835-45
    Golden-Mason L et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Holmkvist P et al. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur. J. Immunol. 2016 Jun;46(6):1371-82
    Holmkvist P et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Jones RB et al. A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. PLoS Pathog. 2016 Apr;12(4):e1005545
    Jones RB et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Kavazović I et al. NKG2D stimulation of CD8(+) T cells during priming promotes their capacity to produce cytokines in response to viral infection in mice. Eur. J. Immunol. 2017 Jul;47(7):1123-1135
    Kavazović I et al
    2017/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed